Home/Filings/4/0001562180-23-003514
4//SEC Filing

WILLIAMS DOUGLAS E 4

Accession 0001562180-23-003514

CIK 0001770121other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:26 PM ET

Size

9.1 KB

Accession

0001562180-23-003514

Insider Transaction Report

Form 4
Period: 2023-04-10
WILLIAMS DOUGLAS E
EVP & President, R&D
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-10+1,100,0001,100,000 total
    Exercise: $3.28Exp: 2033-04-09Common Stock (1,100,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on April 10, 2024 and in 36 equal monthly installments thereafter.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001184847

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:26 PM ET
Size
9.1 KB